BIOMAT Database Logo BIOMAT Database Logo

[Naprosyn, a new nonsteroid antirheumatic agent with a long biological half-life]. 1978

K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013167 Spondylitis, Ankylosing A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions. Ankylosing Spondylitis,Bechterew Disease,Marie-Struempell Disease,Rheumatoid Spondylitis,Spondylarthritis Ankylopoietica,Ankylosing Spondylarthritis,Ankylosing Spondyloarthritis,Bechterew's Disease,Spondylitis Ankylopoietica,Spondyloarthritis Ankylopoietica,Ankylosing Spondylarthritides,Ankylosing Spondyloarthritides,Bechterews Disease,Marie Struempell Disease,Spondylarthritides, Ankylosing,Spondylarthritis, Ankylosing,Spondylitis, Rheumatoid,Spondyloarthritides, Ankylosing,Spondyloarthritis, Ankylosing

Related Publications

K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Clinical experiences with Voltaren a new nonsteroid antirheumatic agent].
January 1975, Wiener medizinische Wochenschrift (1946),
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Treatment of progressive chronic polyarthritis with a non-steroidal antirheumatic agent with a long half-life].
May 1979, Fortschritte der Medizin,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[New nonsteroid antirheumatic drugs in opthalmology].
November 1971, Ceskoslovenska oftalmologie,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Frequency of administration of nonsteroidal antirheumatic agents with a long biological half-life. A clinical trial with piroxicam].
February 1984, Fysiatricky a reumatologicky vestnik,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Nonsteroid antirheumatic agents].
July 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Nonsteroid antirheumatic agents].
March 1978, ZFA. Zeitschrift fur Allgemeinmedizin,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Experiences with a new antirheumatic agent].
July 1965, Die Medizinische Welt,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
[Clinical experiences with a new antirheumatic agent].
April 1963, Medizinische Monatsschrift,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
INDOMETHACIN: A NEW ANTIRHEUMATIC AGENT.
July 1964, Minnesota medicine,
K Pavelka, and O Vojtísek, and J Malecek, and A Brémová, and D Kańková, and A Susta
Biological half-life of a 95mtechnetium labeled bone imaging agent.
December 1976, Health physics,
Copied contents to your clipboard!